Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP515701.RAT1QmZ06cJYPGmskff3gSWkngqAgnOVLTNAaMAJ0eqZE130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP515701.RAT1QmZ06cJYPGmskff3gSWkngqAgnOVLTNAaMAJ0eqZE130_provenance.
• NP924275.RAidxJ-tiTbXmEydSwSETxtsrSc_KnfFgGfngtJctpPfI130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924275.RAidxJ-tiTbXmEydSwSETxtsrSc_KnfFgGfngtJctpPfI130_provenance.
• NP274807.RAsie8koastQbL0olAeK8lvbTni_jkjyYPgdNh_D6PFRs130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP274807.RAsie8koastQbL0olAeK8lvbTni_jkjyYPgdNh_D6PFRs130_provenance.
• NP591635.RAmCXSZbKiM1EejwoX4SFKikTw-XuevWEnLHo37jtV2hE130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591635.RAmCXSZbKiM1EejwoX4SFKikTw-XuevWEnLHo37jtV2hE130_provenance.
• NP667366.RAkqIIy9xgbcdht6apBNzgXvmctSRIQP5O-1YRSi0o94M130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667366.RAkqIIy9xgbcdht6apBNzgXvmctSRIQP5O-1YRSi0o94M130_provenance.
• NP166148.RAwIZ8h8G09qCjSnEdl-ccUoJt2gkLP9gMf9HWxKx0-Fk130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166148.RAwIZ8h8G09qCjSnEdl-ccUoJt2gkLP9gMf9HWxKx0-Fk130_provenance.
• NP353341.RAIWHVE4jfyn0zl0stcLefxUR_h0TKKxykwqsFueBJakE130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353341.RAIWHVE4jfyn0zl0stcLefxUR_h0TKKxykwqsFueBJakE130_provenance.
• NP757349.RAfrgRNSsUd5UkQLFTIdSuk9n72FvPJpJFpIqN0vxUV20130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757349.RAfrgRNSsUd5UkQLFTIdSuk9n72FvPJpJFpIqN0vxUV20130_provenance.
• NP503336.RAxicgUabXUgSavwa28LzcxJ5lFtFGRixsJzsewdb9YnQ130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503336.RAxicgUabXUgSavwa28LzcxJ5lFtFGRixsJzsewdb9YnQ130_provenance.
• NP737734.RAxSDOf10MeNI4DHHONLliqP7AHILmlPYT2MuZVNudG8I130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737734.RAxSDOf10MeNI4DHHONLliqP7AHILmlPYT2MuZVNudG8I130_provenance.
• NP621468.RAdETej5vW8iFfa7pLZYrJB95bh0BAbjTrqycIZG9JSz8130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621468.RAdETej5vW8iFfa7pLZYrJB95bh0BAbjTrqycIZG9JSz8130_provenance.
• NP622890.RAehRvnQyeKFo-8Yk01cwq7DZw7Mt72UQywITgdhKO-RI130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622890.RAehRvnQyeKFo-8Yk01cwq7DZw7Mt72UQywITgdhKO-RI130_provenance.
• NP537033.RAOKyu-Is1lKSI2uoBZ-ILDSY2hZVuz-ZpKGhM5CNvKeU130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537033.RAOKyu-Is1lKSI2uoBZ-ILDSY2hZVuz-ZpKGhM5CNvKeU130_provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1069608.RAXvXs1BEfAPAYi30SbEH7Ow9D4-xNkCiuzoJMuTZU9IQ130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069608.RAXvXs1BEfAPAYi30SbEH7Ow9D4-xNkCiuzoJMuTZU9IQ130_provenance.
• NP590521.RApA8BWmaRM9T8xTaPUZI8Hw21ROyqKtxBAydkUwwggPY130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590521.RApA8BWmaRM9T8xTaPUZI8Hw21ROyqKtxBAydkUwwggPY130_provenance.
• NP232497.RAv81VZ0-NVHwouzlp-PAMe3admJ66xZH_Us2cIdjHBAg130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232497.RAv81VZ0-NVHwouzlp-PAMe3admJ66xZH_Us2cIdjHBAg130_provenance.
• NP621638.RAuQM-Vx0_M5bhV0LWGN3vAw79nrt82KifgY9qkcb2vt8130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621638.RAuQM-Vx0_M5bhV0LWGN3vAw79nrt82KifgY9qkcb2vt8130_provenance.
• NP625345.RAtqdlauAetknYsjmnVDU3gWEEG86FXgTWiXky1NkweJs130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625345.RAtqdlauAetknYsjmnVDU3gWEEG86FXgTWiXky1NkweJs130_provenance.
• NP1069611.RAodH5n7amU243qW3ysNewpLGuYRFqp-AENxQIfT4tA2s130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069611.RAodH5n7amU243qW3ysNewpLGuYRFqp-AENxQIfT4tA2s130_provenance.
• NP1069612.RAtBhj6PYSCt9CmecHgCabQWaXaEH16-98342Waa7OEjU130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069612.RAtBhj6PYSCt9CmecHgCabQWaXaEH16-98342Waa7OEjU130_provenance.
• NP1069615.RAkRIFJfzUShm7azl0VNy7wH5YMv6dgU6enFC1R2HmUSU130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069615.RAkRIFJfzUShm7azl0VNy7wH5YMv6dgU6enFC1R2HmUSU130_provenance.
• NP1069617.RAtYiS6Ksh_-SKbhKUvM4imt7rcpVyBxNxe8aJ3qJm_I4130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069617.RAtYiS6Ksh_-SKbhKUvM4imt7rcpVyBxNxe8aJ3qJm_I4130_provenance.
• NP232401.RAIc-ZZC8rPUF1gfAzo6526cKE6Z1cIkUbAL1v7qRBLSw130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232401.RAIc-ZZC8rPUF1gfAzo6526cKE6Z1cIkUbAL1v7qRBLSw130_provenance.
• NP590397.RA1MlLZesR94DzAumtJV3ylzGzGfSwnLu7Ciqq4jY7pyQ130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP590397.RA1MlLZesR94DzAumtJV3ylzGzGfSwnLu7Ciqq4jY7pyQ130_provenance.
• NP622784.RAIjMOFnUA3J-M-Qdyl7yecWcCZyVPApZKNOweHfPH1TI130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622784.RAIjMOFnUA3J-M-Qdyl7yecWcCZyVPApZKNOweHfPH1TI130_provenance.
• NP624100.RALfGGqlSSd87DBoWTDOKejBc-Mu-D4H7wweazYRO07rc130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624100.RALfGGqlSSd87DBoWTDOKejBc-Mu-D4H7wweazYRO07rc130_provenance.
• NP624205.RA-6cSqNBG_wo99nr-4jtf5o96Av3RalS_LSIzlFAiaqY130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624205.RA-6cSqNBG_wo99nr-4jtf5o96Av3RalS_LSIzlFAiaqY130_provenance.
• NP625241.RA4cL-atUAyusD9cPWYWYkiVIz51YEifejqBatDHUNgY4130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625241.RA4cL-atUAyusD9cPWYWYkiVIz51YEifejqBatDHUNgY4130_provenance.
• NP1069614.RAKE1PtA_jh_FraKrd6amJ5QGw6LRzMCwlX7Ss9x3qnv8130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069614.RAKE1PtA_jh_FraKrd6amJ5QGw6LRzMCwlX7Ss9x3qnv8130_provenance.
• NP1069619.RALvP_6KKtS6dqutxAvGdKdQf5nttPqG02Hs0xVwFTNt0130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069619.RALvP_6KKtS6dqutxAvGdKdQf5nttPqG02Hs0xVwFTNt0130_provenance.
• NP1069620.RAGOKMxXr4t-8hR3zh9HSlRvxqkZHPgmgkL2KoZBstsus130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069620.RAGOKMxXr4t-8hR3zh9HSlRvxqkZHPgmgkL2KoZBstsus130_provenance.
• NP1069610.RA6qc0qjvuEXEDx8MVI1QUGWfbTDt2MCEWwVW5CZpgwa0130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069610.RA6qc0qjvuEXEDx8MVI1QUGWfbTDt2MCEWwVW5CZpgwa0130_provenance.
• NP1069613.RA1s5tZO4dthAjY_LDpfXiXxvQGWND6QiYx51KxefqcjY130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069613.RA1s5tZO4dthAjY_LDpfXiXxvQGWND6QiYx51KxefqcjY130_provenance.
• NP1069616.RAxlCEu8xUdYT8EeeiSV-rYMcR1eM9abptNWpZOyC9h0A130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069616.RAxlCEu8xUdYT8EeeiSV-rYMcR1eM9abptNWpZOyC9h0A130_provenance.
• NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_assertion description "[IGF1R knockdown suppresses tumor growth and enhances chemosensitivity in pancreatic cancer via the inhibition of PI3K/AKT and NF-?B pathways, and is a promising approach to overcome the chemoresistance of pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069621.RA_ZSzfNM17wpZHVRLlQRA6lVnxwf_qAeVkp1OQjBNMe8130_provenance.